# FAMOTIDINE
> **ANDA218461** · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2024-03-14
## Drug
- **FDA Application Number:** ANDA218461
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FAMOTIDINE
- **Generic name:** Famotidine
- **Active ingredients:** FAMOTIDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** GRAVITI PHARMS
- **First approval:** 2024-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218461)
---
*MORVS · CC0 1.0*